Dr. Sam L. Penza, MD

Dr. Penza practices at OSU Internal Medicine in Columbus, Ohio.

Dr. Penza's NPI, 1356359640, was assigned on August 3, 2006. Dr. Penza graduated from Ohio State University College of Medicine in 1989. Dr. Penza holds Ohio license 35061774.

Dr. Penza's primary practice is OSU Internal Medicine, at 460 W 10th Ave, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-2229.

Dr. Penza's primary practice is OSU Internal Medicine in Columbus, Ohio. Dr. Penza is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Penza to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Penza practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Penza's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Penza is licensed in Ohio.

CMS data shows 324 Medicare services from Dr. Penza across 5 procedure codes in 2024, for 82 Medicare patients. Medicare paid $27,083 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. Penza in 2024. The largest group is 65 to 74, with 51 patients. 72% of them have high blood pressure, and 65% have high cholesterol. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Penza's median patient age at 64, with 36% women.

In 2024, Dr. Penza wrote 179 Medicare Part D claims for 24 patients. 7% of them were for generic drugs. CMS names the drug for 166 of them, across 2 drugs with 11 or more claims each, at $3,241,467 in total drug cost. In 2023, CMS named 104 claims across 3 drugs.

Dr. Penza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 40 papers to Dr. Penza, published from 2011 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation Conditioning and Graft vs Host Disease. Dr. Penza has published most often in Bone Marrow Transplant. Dr. Penza's most frequent co-authors are Sumithira Vasu, MD, Don Michael Benson, MD and Yvonne A. Efebera, MD.

Dmand AI links Dr. Penza to 3 clinical trials, 2 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Hodgkin Disease, Myelodysplastic Syndromes and Leukemia, Myeloid, Acute.

CMS Open Payments shows 388 general payments to Dr. Penza from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Incyte Corporation paid the most, $213,640.

Dr. Penza graduated from Ohio State University College of Medicine in 1989.